GlassScriptPhysician profile
Arthur M Williams
NPI 1811949753
$6,117.02
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,279 · 2020: $1,289 · 2021: $1,369 · 2022: $599 · 2023: $464 · 2024: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,590.24 | 2019-2023 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $809.83 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $758.86 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $614.63 | 2022-2023 | |
| Lilly USA, LLC | $362.11 | 2019-2023 | Amyvid |
| Pfizer INC. | $361.15 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $338.96 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $295.53 | 2019-2021 | |
| Abbott Laboratories | $228.20 | 2022-2023 | Freestyle Libre 3 |
| Merck Sharp & Dohme LLC | $225.96 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $116.15 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.96 | 2019 | |
| Allergan, INC. | $83.85 | 2019 | |
| Eisai INC. | $54.49 | 2019-2020 | |
| Dexcom, INC. | $52.55 | 2021-2023 | Dexcom G6 Transmitter |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $24.91 | 2023 | Gvoke Hypopen |
| Amarin Pharma, INC. | $23.00 | 2019-2020 | |
| Mannkind Corporation | $14.26 | 2019 | |
| Supernus Pharmaceuticals, INC. | $13.75 | 2023 | Qelbree |
| Daiichi Sankyo INC. | $12.85 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.27 | 2021 | |
| Sanofi Pasteur INC. | $11.98 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.